HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of endorphins on heart rate and blood pressure in adult dogs.

Abstract
To investigate the role of opioids in regulating cardiovascular function, we administered delta-opioid receptor agonists D-Ala-D-Leu enkephalin (DADLE) and D-Ala-Met enkephalinamide (DAME), and mu-opioid receptor agonist, a morphiceptin analogue (MA), intracisternally in 13 unanesthetized, chronically instrumented adult dogs in 2 doses (25 and 125 micrograms/kg). After an initial transient drop, the R-R interval increased (peak approximately 25-60 min) postadministration of opioids. The time course and the magnitude of the change in R-R interval depended on the agonist: delta-agonists induced a more prolonged and marked change in R-R interval than mu-agonists at both doses. Mean arterial blood pressure (MAP) increased initially but dropped toward or even below base line 30 min after opioids administration. Atropine, given intravenously or intra-arterially at peak action of agonist in relatively low doses (0.02 mg/kg), induced an AV block followed by a marked decrease in R-R interval. There was also an increase in MAP after atropine. Naloxone, given intracisternally, reversed both delta- and mu-opioid effects but did not induce changes in the R-R interval without prior administration of opioids. We conclude that in unanesthetized adult dogs 1) both mu- and delta-receptor opioid agonists prolong the R-R interval, and this depends on the type of receptor stimulated; 2) opioids induce slowing in heart rate, possibly by increasing parasympathetic activity to the heart; 3) enkephalin and morphiceptin analogues induce a biphasic response in MAP; and 4) endorphins do not modulate cardiovascular function tonically; we speculate that they can alter the R-R interval and MAP in the presence of stimuli.
AuthorsG G Haddad, H J Jeng, T L Lai
JournalThe American journal of physiology (Am J Physiol) Vol. 250 Issue 5 Pt 2 Pg. H796-805 (May 1986) ISSN: 0002-9513 [Print] United States
PMID3518492 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Endorphins
  • Naloxone
  • Enkephalin, Methionine
  • Enkephalin, Leucine
  • Naltrexone
  • enkephalinamide-Met, Ala(2)-
  • Enkephalin, Leucine-2-Alanine
  • Atropine
  • morphiceptin
Topics
  • Animals
  • Atropine (pharmacology)
  • Blood Pressure (drug effects)
  • Consciousness (drug effects)
  • Dogs
  • Endorphins (pharmacology)
  • Enkephalin, Leucine (analogs & derivatives, antagonists & inhibitors, pharmacology)
  • Enkephalin, Leucine-2-Alanine
  • Enkephalin, Methionine (analogs & derivatives, antagonists & inhibitors, pharmacology)
  • Heart (drug effects)
  • Heart Rate (drug effects)
  • Naloxone (pharmacology)
  • Naltrexone (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: